D. Dansette

The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression

C. Volteau, A. Jarry, J. Mosnier, 2019, Modern Pathology.

Loss of SMARCB1 expression in colon carcinoma.

O. Delattre, C. Lepage, J. Mosnier, 2020, Cancer biomarkers : section A of Disease markers.

The density of Tbet+ tumor-infiltrating T lymphocytes reflects an effective and druggable preexisting adaptive antitumor immune response in colorectal cancer, irrespective of the microsatellite status

C. Volteau, M. Denis, A. Jarry, 2019, Oncoimmunology.

The Caspase-1/IL-18 Axis of the Inflammasome in Tumor Cells: A Modulator of the Th1/Tc1 Response of Tumor-Infiltrating T Lymphocytes in Colorectal Cancer

P. Gourraud, C. Brochier, A. Jarry, 2021, Cancers.

Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease

C. Bailly, F. Kraeber-Bodéré, F. Haddad, 2020, Cancers.